Umoja Biopharma Funding & Investors
Seattle, WA
Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer. The company's treatment approach retools a patient’s immune system in vivo to direct potent anti-cancer immune cells to a patient’s tumor, augmenting the body’s natural mechanisms for fighting cancer.
umoja-biopharma.comTotal Amount Raised: $263,000,000
Umoja Biopharma Funding Rounds
Series B
$210,000,000
Series B Investors
Cormorant Asset ManagementSoftBank Vision FundCaaS Capital ManagementTemasekPresight CapitalRTW InvestmentsLeerink SwannSeries A
$53,000,000
Series A Investors
MPM CapitalQiming Venture Partners USADCVC
Funding info provided by Diffbot.